Cabaletta Bio Reports Positive Rese-cel Data Across Myositis, SSc, and SLE Trials
Cabaletta Bio Inc. (NASDAQ:CABA) is one of the best stocks under $3 to invest in.
Cabaletta Bio Inc. (CABA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,522,583 | $3,334,457 | +14% | 0.01% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 959,076 | $2,100,376 | -28% | 0% |
| 3. | Stonepine Capital Timothy P. Lynch | 171,100 | $374,709 | 0.27% | |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 149,094 | $326,516 | +1157% | 0% |
| 5. | Hudson Bay Capital Management Sander Gerber | 138,729 | $303,817 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.26 | 8,800 | $19,888.00 | 8,800 | 2026-01-21 | Filing | |
| $2.19 | 11,312 | $24,763.10 | 31,312 | 2026-01-21 | Filing | |
| $2.21 | 22,725 | $50,322.24 | 22,725 | 2026-01-21 | Filing | |
| $2.27 | 22,170 | $50,215.05 | 22,170 | 2026-01-21 | Filing | |
| $2.27 | 4,405 | $9,982.17 | 5,405 | 2026-01-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.33 | 700 | $14,228.62 | 20,000 | 2024-01-19 | Filing | |
| $19.54 | 10,300 | $201,210.50 | 20,700 | 2024-01-19 | Filing | |
| $22.22 | 3,132 | $69,593.35 | 20,000 | 2023-12-19 | Filing | |
| $21.76 | 7,868 | $171,195.88 | 23,132 | 2023-12-19 | Filing | |
| $18.02 | 7,458 | $134,405.09 | 20,000 | 2023-11-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,905,699 | $19,503,481 | 0.01% | |
| 2. | 4,419,458 | $9,678,613 | 0% | |
| 3. | 2,328,470 | $5,099,349 | 0% | |
| 4. | 1,343,708 | $2,942,720 | 0% | |
| 5. | 1,085,816 | $2,378,961 | 0% |
News See All
10 Best Stocks Under $3 to Invest In
On October 16, Victoria Greene, Chief Investment Officer of G Squared Private Wealth Management, appeared on CNBC to state that small caps demonstrate lasting strength.
Several Headwinds Dragged Cabaletta Bio (CABA) in Q2
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
Jim Cramer’s 10 Latest Stock Picks This Week
Jim Cramer in his latest program talked about the ever-growing appetite for semiconductor chips in the market, demonstrating the enormous gains of semiconductor ETFs, in addition to semiconductor stocks...
Several Factors Led to the Outperformance of Cabaletta Bio (CABA) in Q4
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best-Performing Stocks in the Last 12 Months
Property and casualty insurance company United Insurance Holdings Corp. (NASDAQ:UIHC) has been one of the best-performing stocks over the past one year.
12 Most Promising Micro-Cap Stocks According to Analysts
In this article, we will take a look at the 12 most promising micro-cap stocks according to analysts.
Hedge Fund and Insider Trading News: Cathie Wood, Ray Dalio, Irenic Capital Management, Schonfeld Strategic Advisors, BlueCrest Capital Management, Man Group, Cabaletta Bio Inc (CABA), JPMorgan Chase & Co. (JPM), and More
Irenic Capital Management, a hedge fund that owns a 1.5% stake in Capricorn Energy Plc (CNE.L), asked the natural gas producer on Wednesday to abandon its sale to Israel's NewMed Energy LP (NWMDp.TA) ...
10 Cheap Pharmaceutical Stocks to Watch
In this article, we discuss the 10 cheap pharmaceutical stocks to watch.
Hedge Fund Resource Center Billionaire Hedge Funds
